Mert KÜÇÜK, SELDA DEMİRCAN SEZER, MUSTAFA OĞURLU, Hasan YÜKSEL, Bakiye UĞUR, Ali Rıza ODABAŞI

Kardiak Transplantasyon Gerektiren Peripartum Kardiyomyopati: Olgu Sunumu

Giriş: Peripartum kardiyomyopati, dilate kardiyomyopatinin gebeliğin son aylarında veya doğumdan sonra ay içinde görülen ve kalp yetmezliği semptomları ile karakterize olan bir formudur. Olgu: Bu yazıda, öksürük ve dispne şikayeti ile başvuran, 38,5 hafta gebelik vefetal distres nedeni ile acil sezaryen abdominale uygulanan ve peripartum kardiyomyopati gelişen bir gebe olgu sunuldu. Hastaya doğum sonrası sevk edildiği merkezde doğumdan ay sonra kardiyak transplantasyon yapıldı. Hasta ve çocuğu doğumdan 26 ay sonra sağlıklı olarak yaşamına devam etmektedirler. Sonuç: Sonuç olarak peripartum kardiyomyopati gebeliğin son aylarında veya doğumdan sonraki ilk aylarda görülebilen nispeten nadir ama hayatı tehdit edici bir sendromdur. Peripartum kardiyomyopati bulgularının sıklıkla gebeliğin son aylarındaki gebelik semptomları veya solunum sistemi hastalıkları ile karışması nedeniyle, klinisyenlerin peripartum kardiyomyopati tanı ve tedavisi konusunda bilgili ve dikkatli olmaları gerektiği kanısındayız.

Peripartum Cardiomyopathy Requiring Cardiac Transplantation: A Case Report

Introduction: Peripartum cardiomyopathy characterized by heartfailure symptoms is form ofdilated cardiomyopathy which occurs in the last months ofpregnancy or within months after delivery Case: In this article, 38.5 weeks pregnant woman with complaints of cough and dyspnea who underwent an emergency cesarean section due to fetal distress and developed peripartum cardiomyopathy is presented. Thepatient underwent cardiac transplantation months after birth at the center where she was referred after birth. The patient and her child 26 months after birth, continue in healthy life. Conclusion: As result, peripartum cardiomyopathy can be seen in the last months of pregnancy, or in the first months after birth and is relatively rare but life-threatening syndrome. Because signs ofperipartum cardiomyopathy are often similar with pregnancy symptoms or signs of respiratory diseases in the last months ofpregnancy, clinicians must be aware and informed about the diagnosis and treatment of peripartum cardiomyopathy.

PDF

___

1. Gouley BA, McMillan TM, Bellet S. Idiopathic myocardial degeneration associated with pregnancy and especially the peripartum. Am J Med Sci 193 7; 19:185-199
2. Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, Gunnar RM Natural course of peripartum cardiomyopathy. Circulation. 1971 Dec;44(6):1053-61.
3. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg 0, Kiihl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardia! Diseases. Eur Heart J. 2008 Jan;29(2):270-6. Epub 2007 Oct4.
4. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000 Mar 1;283(9):1183-8. 5. Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc. 2005 Dec;80(12): 1602-6.
6. Lang RM, Lampert MB, Poppas A, et al: Peripartal cardiomyopathy. In: Cardiac Problems in Pregnancy. 3rd ed Elkayam U, Gleicher N (Eds). New York, NY, Wiley-Liss, 1998, pp 87-100
7. Murali S, Baldisseri MR. Peripartum cardiomyopathy. Crit Care Med 2005 Oct;33(10 Suppl):S340-6.
8. Ramaraj R, Sorrell VL. Peripartum cardiomyopathy: Causes, diagnosis, and treatment. Cleve Clin J Med. 2009 May;76(5):289-96.
9. Moioli M, Valenzano Menada M, Bentivoglio G, Ferrero S. Peripartum cardiomyopathy. Arch Gynecol Obstet. 2010 Feb;281(2):183-8. Epub 2009Aug 5.
10. O'Connell JB, Costanzo-Nordin MR, Subramanian R, Robinson JA, Wallis DE, Scanlon P J, Gunnar RM Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics. J Am Colt Cardiol. 1986 Ju/;8(1):52-6.
11. Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL. Peripartum myocarditis and cardiomyopathy. Circulation. 1990 Mar;81(3):922- 8.
12. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Eng! J Med. 2000 Apr 13;342(15): 1077-84.
13. Hayakawa Y, Chandra M, Miao W, Shirani J, Brown JH, Dorn GW 2nd, Armstrong RC, Kitsis RN. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy ofGalpha(q) transgenic mice. Circulation. 2003 Dec 16;108(24):3036-41.
14. Nelson JL. Microchimerism: expanding new horizon in human health or incidental remnant of pregnancy? L ancet. 2001 Dec 15;358(9298):2011- 2. CiLT: 42 YIL: 2011 SAYI: I
15. Mann MS, Cossham PS, Baker JL, Hurley PA. Left atrial myxoma in the second trimester of pregnancy. Case report. Br J Obstet Gynaecol. 1987 Jun;94(6):592-3.
16. Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc. 1989 Oct;64(10):1235-45.
17. DiBella G, de Gregorio C, Minutoli F, Pingitore A, Coglitore S, Arrigo F, Carer} S. Early diagnosis of focal myocarditis by cardiac magnetic resonance. Int J Cardiol. 2007 Apr 25;117(2):280-1.
18. Ferrero S, Colombo BM, Fenini F, Abbamonte LH, Arena E. Peripartum cardiomyopathy. A review. Minerva Ginecol. 2003 Apr;55(2):139-51, 151-8.
19. Narin C, Reyhanoglu H, Tulek B, Onoglu R, Ege E, Sarigul A, Yeniterzi M, Durmaz I. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy. Adv Ther. 2008 Jun;25(6):585-94.
20. White WB. Management of hypertension during lactation. Hypertension. 1984 May-Jun;6(3):297- 300.
21. Stempel JE, O'GradyJP, Morton MJ, Johnson KA. Use of sodium nitroprusside in complications of gestational hypertension. Obstet Gynecol. 1982 Oct;60(4):533-8.
22. Hilfiker-Kleiner D, Meyer GP, Schieffer E, Goldmann B, Podewski E, Struman L Fischer P, Drexler H. Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. JAm Colt Cardiol. 2007 Dec 11;50(24):2354-5.
23. Shotan A, Widerhorn J, Hurst A, Elkayam U Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med. 1994 May;96(5):451-6.
24. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA. Major congenital malformations qfter first-trimester exposure to ACE inhibitors. N Eng! J Med 2006 Jun 8;354(23):2443-51